ROIV vs UTHR
Roivant Sciences Ltd. · United Therapeutics Corporation
Relative return (rebased to 100)
Key stats
| Metric | ROIV | UTHR |
|---|---|---|
| Price | $34.59 | $550.10 |
| Market Cap | $24.99B | $23.59B |
| P/E | — | 17.68 |
| P/B | 5.90 | 3.69 |
| P/S | 3024.84 | 7.41 |
| ROE | -7.1% | 20.9% |
| Net Margin | -3629.2% | 41.9% |
| Gross Margin | — | 87.9% |
| Revenue Growth | -71.6% | 10.6% |
| Dividend Yield | — | — |
| EPS | -$0.42 | $31.12 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.